Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.
SCHOTT Pharma AG & Co. KgaA
FOLLOW
SCHOTT Pharma is a leading global provider of pharmaceutical packaging solutions, specialising in primary drug containment solutions and delivery systems for injectable medications.
Human health matters. That is why SCHOTT Pharma designs containment solutions grounded in science to ensure that medications are safe and easy to use for people around the world. More than 30,000 people use a SCHOTT Pharma product-packed injection every minute.
The portfolio consists of drug containment solutions and delivery systems for injectable drugs, varying from prefillable glass and polymer syringes to cartridges, vials, and ampoules. SCHOTT Pharma’s team comprises around 4,800 people from more than 65 nations.
The company is represented in all main pharmaceutical hubs with 17 manufacturing sites in Europe, North and South America, and Asia. With over 1,000 patents and technologies developed in-house and a state-of-the-art R&D centre in Switzerland, the company is focused on developing innovations for the future. Currently, SCHOTT Pharma has over 1,800 customers, including the top 30 leading pharma manufacturers for injectable drugs and generated revenue of EUR 986 million in the financial year 2025.
SCHOTT Pharma AG & Co. KGaA is headquartered in Mainz, Germany and listed on the Frankfurt Stock Exchange as part of the SDAX. It is majority owned by SCHOTT AG, which is owned by the Carl Zeiss Foundation. In light of this spirit, SCHOTT Pharma is committed to sustainable development for society and the environment. Further information at www.schott-pharma.com
SCHOTT Pharma’s core business is manufacturing advanced primary packaging for injectable drug products. The portfolio is divided into Drug Containment Solutions (e.g. vials, cartridges, ampoules) and Drug Delivery Systems (prefillable syringes and related devices).
The portfolio consists of glass vials, glass ampoules, glass and polymer cartridges, as well as glass and polymer syringes.
All products are made to stringent quality standards using high-performance materials like Type I borosilicate glass and medical-grade cyclic olefin copolymer.
With its comprehensive service offering, SCHOTT Pharma supports the entire drug development life cycle, from research through commercialisation. The services range from developing solutions for drug containment and delivery to performing packaging-related analytical tests and optimising fill-and-finish processes, as well as providing sustainability and regulatory support.
Whether made of glass or advanced polymer, SCHOTT Pharma’s prefillable syringes (PFS) offer a highly stable, long-term storage solution and a safe, convenient delivery system for patients and healthcare professionals.
By reducing the number of manual preparation steps compared to conventional packaging, PFS significantly lower the risk of medical errors and contamination, enhancing safety and reducing drug waste.
SCHOTT Pharma’s syringe portfolio is based on a versatile approach to materials, with two complementary platforms:
This dual offering enables pharmaceutical companies to select the most appropriate solution based on drug formulation, delivery method, and application setting, ensuring optimal performance without compromise.
Pharmaceutical cartridges are cylindrical containers (for devices such as pen injectors, autoinjectors and wearable devices) that enable accurate multi-dose delivery. Crafted from high-quality glass tubing or advanced polymers, SCHOTT Pharma’s cartridges are known for robust construction and exceptionally accurate dosing performance.
They fit a wide range of injection devices to ensure smooth operation and patient safety. SCHOTT Pharma provides ready-to-use cartridges under its cartriQ® brand, including specialised designs for different drug requirements.
For instance, double-chamber cartridges allow convenient reconstitution of lyophilised drugs, and break-resistant cartridges withstand high pressure or shock during use. With SCHOTT TOPPAC® cartridge, made from highly advanced Cyclic Olefin Copolymer (COC), SCHOTT Pharma provides the first ISO-standardised ready-to-use (RTU) polymer cartridge designed for the sterile administration of highly sensitive biologics, including cell and gene therapies, biosimilars, and emergency drugs.
Glass vials are a cornerstone of SCHOTT Pharma’s product range, used to contain injectable liquids, lyophilised drugs, and vaccines. SCHOTT Pharma’s vials are made from Type I borosilicate glass, offering high chemical resistance to minimise drug-container interactions. This ensures that medications – including sensitive biologics – remain stable over shelf life without significant leachables or pH shifts.
The vials have tight dimensional tolerances and superior cosmetic quality to support efficient high-speed filling and secure container closure integrity. For example, the adaptiQ® system provides ready-to-use vials in nest-and-tub formats for streamlined fill-finish processing.
SCHOTT Pharma also offers pioneering vial solutions under its EVERIC® family to answer specialised needs. EVERIC® vials feature ultra-clean inner surfaces and other enhancements to improve drug stability and safety.
For instance, EVERIC® pure vials have a homogeneous inner glass surface for unmatched drug stability. There are also variants for specific applications under the EVERIC® concept – for example, vials for deep-frozen biologics, highly sensitive formulations, or unique identifiers to support track-and-trace of individual containers. This modular approach helps clients choose optimal vials for their needs while ensuring compatibility with standard filling lines.
SCHOTT Pharma produces classic glass ampoules, reflecting the company’s long heritage. Ampoules are sealed single-dose containers opened by breaking the neck. SCHOTT Pharma’s ampoules are made from Type I glass with high chemical resistance and precise dimensions, ensuring drug stability until the point of use. The company also offers safety-enhanced versions: easyOPC ampoules have a scored neck for easier, controlled opening, and Anti-Counterfeiting (AC) ampoules use unique ring markings to deter tampering and fraud.
Beyond its products, SCHOTT Pharma offers value-added services to support clients from early drug development through commercialisation. Experts assist with everything from packaging design and material selection to laboratory analytics and regulatory filings, ensuring the packaging works optimally with the drug and meets compliance requirements. The company also emphasises sustainability in packaging, collaborating with customers to reduce carbon footprint.
SCHOTT Pharma addresses emerging industry challenges through targeted packaging solutions aligned with current trends. For example, as biologic drugs and biosimilars become more common, the company drives container innovation to maintain their stability (minimising glass delamination, protein interactions, etc.).
To facilitate self-administration, SCHOTT Pharma provides options for delivering large-volume biologics subcutaneously – such as optimised polymer syringe systems, large-volume sterile glass and polymer cartridges and syringes – that accommodate high-viscosity drugs and enable high-speed, quality-consistent filling.
To facilitate self-administration, SCHOTT Pharma provides a broad range of options for subcutaneous large‑volume biologics — from optimised polymer syringe systems to large‑volume glass and polymer cartridges. These solutions are designed to accommodate high‑viscosity drugs while ensuring high‑speed, quality‑consistent filling.
Through continuous innovation in these areas, SCHOTT Pharma serves as a strategic partner to drug makers, helping overcome packaging hurdles as new therapies come to market.
EVERIC® Pure – The Safe Option Right from the Start